Site Map
Product Pages Catalogue Numbers 1201 - 1300
| Cat. No. | Product Name & Pharmacological Action |
|---|---|
| 1201 | Phorbol 12-myristate 13-acetate |
| Protein kinase C activator | |
| 1202 | SB 203580 |
| Selective inhibitor of p38 MAPK | |
| 1203 | MRS 2219 |
| Potentiates P2X1-mediated responses | |
| 1205 | SR 57227 hydrochloride |
| Potent, selective 5-HT3 agonist | |
| 1206 | SC 19220 |
| Selective EP1 receptor antagonist | |
| 1207 | BRL 15572 hydrochloride |
| Selective h5-HT1D antagonist | |
| 1208 | (2R,4R)-APDC |
| Highly selective group II agonist | |
| 1209 | LY 341495 |
| Highly potent, selective group II antagonist | |
| 1210 | FR 139317 |
| Highly potent, selective ETA antagonist | |
| 1211 | ZD 7155 hydrochloride |
| Selective non-peptide AT1 antagonist | |
| 1212 | MPEP hydrochloride |
| mGlu5 antagonist and positive allosteric modulator at mGlu4 | |
| 1213 | PD 98059 |
| Specific inhibitor of MEK | |
| 1214 | SIB 1893 |
| mGlu5 antagonist and positive allosteric modulator at mGlu4 | |
| 1215 | SIB 1757 |
| Highly selective mGlu5 antagonist | |
| 1217 | MRS 1220 |
| Highly potent, selective hA3 antagonist | |
| 1218 | DH 97 |
| MT2 receptor antagonist | |
| 1219 | IDRA 21 |
| Inhibits AMPA receptor desensitisation | |
| 1220 | (RS)-PPG |
| Potent, selective mGlu8 agonist | |
| 1221 | SB 224289 hydrochloride |
| Selective 5-HT1B antagonist | |
| 1222 | DMPQ dihydrochloride |
| Potent, selective inhibitor of β-type PDGFRTK | |
| 1223 | DL-TBOA |
| Potent, selective non-transportable inhibitor of EAATs | |
| 1224 | 2-APB |
| IP3 receptor antagonist. Also TRP channel modulator | |
| 1226 | Etoposide |
| Topoisomerase II inhibitor | |
| 1227 | Apigenin |
| Anticancer agent | |
| 1228 | Nocodazole |
| Microtubule inhibitor | |
| 1229 | Actinomycin D |
| Antineoplastic antibiotic | |
| 1230 | Methotrexate |
| Cytotoxic agent | |
| 1231 | Brefeldin A |
| Disrupts protein translocation to Golgi | |
| 1232 | Wortmannin |
| Potent, irreversible inhibitor of PI 3-kinase. Also inhibitor of PLK1 | |
| 1233 | Cytochalasin D |
| Disrupts actin filament function | |
| 1234 | A23187, free acid |
| Calcium ionophore | |
| 1235 | Cyclopiazonic Acid |
| Inhibitor of SERCA ATPase | |
| 1236 | BHQ |
| Inhibitor of SERCA ATPase | |
| 1237 | LY 367385 |
| Selective mGlu1a antagonist | |
| 1238 | CCMQ |
| Used to characterise NR2B-containing NMDA receptors | |
| 1239 | Ac-RYYRIK-NH2 |
| High affinity ORL1 ligand | |
| 1240 | NF 023 |
| Selective, competitive P2X antagonist | |
| 1241 | CGS 19755 |
| Potent, competitive NMDA antagonist | |
| 1242 | SB 216641 hydrochloride |
| Selective h5-HT1B antagonist | |
| 1243 | (+)-PD 128907 hydrochloride |
D3 agonist (D3 ³ D2 > D4) |
|
| 1244 | KB-R7943 mesylate |
| Na+/Ca2+ exchange inhibitor (reverse mode) | |
| 1245 | CGP 35348 |
| Brain penetrant, selective GABAB antagonist | |
| 1246 | CGP 52432 |
| Potent, selective GABAB antagonist | |
| 1247 | CGP 46381 |
| Brain penetrant, selective GABAB antagonist | |
| 1248 | CGP 55845 |
| Potent, selective GABAB antagonist | |
| 1249 | CY 208-243 |
Selective D1-like agonist |
|
| 1250 | SDZ 220-581 |
| Competitive NMDA antagonist, centrally active | |
| 1251 | SDZ 220-040 |
| Potent, competitive NMDA antagonist | |
| 1253 | (S)-WAY 100135 dihydrochloride |
| Potent, selective 5-HT1A antagonist | |
| 1254 | Y-27632 dihydrochloride |
| Selective p160ROCK inhibitor | |
| 1255 | SDZ SER 082 fumarate |
| Selective 5-HT2B/2C antagonist | |
| 1256 | Vinblastine sulfate |
| Disrupts microtubules | |
| 1257 | Vincristine sulfate |
| Disrupts microtubules | |
| 1258 | 1-Deoxynojirimycin |
| Glucosidase I and II inhibitor | |
| 1259 | 1-Deoxymannojirimycin hydrochloride |
| α-Mannosidase I inhibitor | |
| 1260 | Ivermectin |
| Modulates glutamate/GABA-activated CI- channels | |
| 1261 | EHNA hydrochloride |
| Adenosine deaminase inhibitor | |
| 1262 | SR 95531 hydrobromide |
| Selective, competitive GABAA receptor antagonist | |
| 1263 | GR 144053 trihydrochloride |
| Fibrinogen (glycoprotein IIb/IIIa) receptor antagonist. Antithrombotic | |
| 1264 | SB 202190 |
| Potent, selective inhibitor of p38 MAPK | |
| 1265 | D-CPP-ene |
| Potent, competitive NMDA antagonist | |
| 1266 | Nociceptin (1-7) |
| Bioactive metabolite of nociceptin | |
| 1267 | Pifithrin-α hydrobromide |
| p53 inhibitor. Also aryl hydrocarbon receptor agonist | |
| 1268 | U 73122 |
| Phospholipase C inhibitor | |
| 1274 | GR 159897 |
| Non-peptide, potent NK2 antagonist | |
| 1276 | AG 1478 hydrochloride |
| Highly potent EGFR-kinase inhibitor | |
| 1277 | KN-62 |
| Non-competitive P2X7 antagonist | |
| 1278 | KN-93 |
| CaM kinase II inhibitor. Also K+ channel blocker (KV) | |
| 1282 | GNTI dihydrochloride |
| Potent, selective κ antagonist | |
| 1283 | ARL 67156 trisodium salt |
| Ecto-ATPase inhibitor | |
| 1284 | Olomoucine |
| Cyclin-dependent kinase inhibitor | |
| 1285 | Staurosporine |
| Non-selective protein kinase inhibitor | |
| 1288 | KT 5720 |
| Selective protein kinase A inhibitor | |
| 1289 | KT 5823 |
| Selective protein kinase G inhibitor | |
| 1290 | Anisomycin |
| Protein synthesis inhibitor | |
| 1291 | Ochratoxin A |
| Stimulates SERCA-ATP-dependent Ca2+ pump activity | |
| 1292 | Rapamycin |
| Immunosuppressant | |
| 1295 | Loreclezole hydrochloride |
| Subtype-selective GABAA receptor modulator | |
| 1296 | CI 966 hydrochloride |
| Selective inhibitor of GAT-1 | |
| 1297 | Abn-CBD |
Neurobehaviourally inactive cannabinoid |
|
| 1298 | 2-Arachidonylglycerol |
Endogenous cannabinoid agonist |
|
| 1300 | LFM-A13 |
| Potent, selective BTK inhibitor | |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | All |
[top]